Steger G - Search Results

1

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.

Gnant M, Mlineritsch B, Stoeger H, Luschin-Ebengreuth G, Knauer M, Moik M, Jakesz R, Seifert M, Taucher S, Bjelic-Radisic V, Balic M, Eidtmann H, Eiermann W, Steger G, Kwasny W, Dubsky P, Selim U, Fitzal F, Hochreiner G, Wette V, Sevelda P, Ploner F, Bartsch R, Fesl C, Greil R; Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. Gnant M, et al. Among authors: steger g. Ann Oncol. 2015 Feb;26(2):313-20. doi: 10.1093/annonc/mdu544. Epub 2014 Nov 17. Ann Oncol. 2015. PMID: 25403582 Free article. Clinical Trial.

2

DNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomised study.

Gnant MF, Blijham G, Reiner A, Reiner G, Reynders M, Schutte B, van Asche C, Steger G, Jakesz R. Gnant MF, et al. Among authors: steger g. Eur J Cancer. 1992;28(2-3):711-6. doi: 10.1016/s0959-8049(05)80132-7. Eur J Cancer. 1992. PMID: 1591097 Clinical Trial.

3

[Current status of adjuvant therapy in patients with colorectal cancer: report and commentary on the Consensus Conference, 16-18 April 1990, National Cancer Institute, Bethesda, Maryland].

Steger G, Jakesz R. Steger G, et al. Wien Klin Wochenschr. 1991;103(4):117-21. Wien Klin Wochenschr. 1991. PMID: 1710398 Review. German.

4

Vindesine-epirubicin versus vindesine-mitoxantrone in metastatic breast cancer.

Hausmaninger H, Lehnert M, Steger G, Sevelda P, Michlmayr G, Hehenwarter W, Fridrik M, Samonigg H, Schiller L, Manfreda D, et al. Hausmaninger H, et al. Among authors: steger g. Onkologie. 1989 Oct;12(5):225-9. doi: 10.1159/000216651. Onkologie. 1989. PMID: 2685688 Clinical Trial.

5

Escalating dose regimen of intraperitoneal mitoxantrone: phase I study--clinical and pharmacokinetic evaluation.

Blöchl-Daum B, Eichler HG, Rainer H, Jakesz R, Salzer H, Steger G, Schüller J, Günther E, Proksch B, Ehninger G. Blöchl-Daum B, et al. Among authors: steger g. Eur J Cancer Clin Oncol. 1988 Jul;24(7):1133-8. doi: 10.1016/0277-5379(88)90119-8. Eur J Cancer Clin Oncol. 1988. PMID: 3416898

6

Possible adverse effect of failed adjuvant chemotherapy on the prognosis of women receiving consecutive chemotherapy for recurrent breast cancer.

Dittrich C, Jakesz R, Pirich K, Havelec L, Steger G, Schlappack O, Kolb R, Moser K. Dittrich C, et al. Among authors: steger g. J Cancer Res Clin Oncol. 1987;113(5):488-94. doi: 10.1007/BF00390044. J Cancer Res Clin Oncol. 1987. PMID: 3624302

7

[Primary (preoperative, neoadjuvant) chemotherapy of colon cancer--a therapeutic alternative?].

Jakesz R, Steger G. Jakesz R, et al. Among authors: steger g. Chirurg. 1994 Jun;65(6):497-502. Chirurg. 1994. PMID: 8088204 Review. German.

8

Aneuploidy fraction but not DNA index is important for the prognosis of patients with stage I and II breast cancer--10-year results.

Gnant MF, Blijham GH, Reiner A, Schemper M, Reynders M, Schutte B, van Asche C, Steger G, Jakesz R. Gnant MF, et al. Among authors: steger g. Ann Oncol. 1993 Sep;4(8):643-50. doi: 10.1093/oxfordjournals.annonc.a058618. Ann Oncol. 1993. PMID: 8240995 Free article.

9

Randomised phase II study of epirubicin-vindesine versus mitoxantrone-vindesine in metastatic breast cancer.

Hausmaninger H, Lehnert M, Steger G, Sevelda P, Tschurtschenthaler G, Hehenwarter W, Fridrik M, Samonigg H, Schiller L, Manfreda D, et al. Hausmaninger H, et al. Among authors: steger g. Eur J Cancer. 1995 Dec;31A(13-14):2169-73. doi: 10.1016/0959-8049(95)00489-0. Eur J Cancer. 1995. PMID: 8652237 Clinical Trial.

10

Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients. Austrian Breast Cancer Study Group.

Jakesz R, Samonigg H, Gnant M, Kubista E, Steindorfer P, Hausmaninger H, Sevelda P, Tschurtschenthaler B, Fridrik M, Stierer M, Kolb R, Steger G. Jakesz R, et al. Among authors: steger g. Eur J Cancer. 1998 Jan;34(1):66-70. doi: 10.1016/s0959-8049(97)10010-7. Eur J Cancer. 1998. PMID: 9624239 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

448 results

Search Page

Filters